Evidence map›Paper›PMID 32334524›Full record

ArticleBMC cardiovascular disorders2020

Pooled cohort equations heart failure risk score predicts cardiovascular disease and all-cause mortality in a nationally representative sample of US adults.

Alexander C Razavi, Kaitlin S Potts, Tanika N Kelly, Jiang He, Camilo Fernandez, Marie Krousel-Wood, Amanda H Anderson, Joshua Bundy, Seamus P Whelton, Roger S Blumenthal and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Alexander C RazaviDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA. arazavi@tulane.edu.
Kaitlin S PottsDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Tanika N KellyDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Jiang HeDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Camilo FernandezDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Marie Krousel-WoodDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Amanda H AndersonDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Joshua BundyDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Seamus P WheltonThe Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Roger S BlumenthalThe Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Donald Lloyd-JonesDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Lydia A BazzanoDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, 1440 Canal Street, Suite 2000, New Orleans, Louisiana, 70112, USA.
Tulane University · USJohns Hopkins University · USNorthwestern University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Elizabeth Engler-Chiurazzi · 2016 to 2026
$25.3M
Childhood CV Risk and Adult CVD Outcomes: an International Long-term Follow-upR01HL121230 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BURNS, TRUDY L, CHEN, WEI · 2015 to 2019
$13.3M
Tulane Building Interdisciplinary Research Careers in Women's Health (BIRCWH)K12HD043451 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KROUSEL-WOOD, MARIE · 2002 to 2023
$9.9M
Obesity Genes, Energy Regulation in Response to Weight-Loss DietsR01DK091718 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI QI, LU · 2012 to 2021
$4.5M
The Role of Vascular Aging in Cognitive and Physical Function - Diversity SupplementR01AG041200 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI BAZZANO, LYDIA · 2012 to 2017
$2.9M
The Gut Microbiome and The Metabolome in Chronic Kidney DiseaseR01DK107566 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI ANDERSON, AMANDA HYRE, WU, GARY D. · 2016 to 2020
$2.8M
Measures of Fibrosis and Clinical Outcomes in Chronic Kidney DiseaseR01DK104730 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI ANDERSON, AMANDA HYRE · 2015 to 2019
$1.9M
Digital biomarkers of Alzheimers-related brain health and functionR21AG057983 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI BAZZANO, LYDIA, URBINA, ELAINE MOTT · 2018 to 2020
$812k
The Roles of the Microbiome and Metabolome in Vascular AgingR21AG051914 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI KELLY, TANIKA NICOLE · 2016 to 2017
$424k
The Roles of the Metabolome and Dietary Protein Intake in Left Ventricular Diastolic FunctionF30HL147486 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI RAZAVI, ALEXANDER C. · 2019 to 2020
$97k
NCATS NIH HHS UL1 TR001417NHLBI NIH HHS F30 HL147486NHLBI NIH HHS R01 HL121230NIA NIH HHS 5 R01 AG041200NIA NIH HHS R01 AG041200NIA NIH HHS R21 AG051914NIA NIH HHS R21 AG057983NICHD NIH HHS K12 HD043451NIDDK NIH HHS R01 DK091718NIDDK NIH HHS R01 DK104730NIDDK NIH HHS R01 DK107566NIGMS NIH HHS P20 GM109036NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

backgroundHeart failure (HF) represents an accumulated burden of systemic vascular damage and is the fastest growing form of cardiovascular disease (CVD). Due to increasing HF-attributable mortality rates, we sought to assess the association of the new 2019 Pooled Cohort equations to Prevent Heart Failure (PCP-HF) risk score with CVD and all-cause mortality.

methodsWe linked data for 6333 black and white men and women aged 40-79 years, whom underwent electrocardiographic examination from the Third National Health and Nutrition Exam Survey, to National Death Index record matches. Sex- and race-specific PCP-HF risk scores were calculated using data on age, smoking, body mass index, systolic blood pressure, total cholesterol, HDL-cholesterol, fasting blood glucose, QRS complex duration, and antihypertensive and/or glucose-lowering medications. Cox regression estimated hazard ratios for the association of the PCP-HF risk score with CVD and all-cause mortality.

resultsIndividuals were on average 54.9 years old (51.7% women, 25.4% black) and the median 10-year HF risk was 1.6% (Q1 = 0.5, Q3 = 4.8). There were 3178 deaths, 1116 from CVD, over a median follow-up time of 22.3 years. Black women had a higher 10-year HF risk compared to white women (2.1% vs. 1.1%; p < 0.01), while no significant difference was observed in predicted HF risk between black men and white men (2.3% vs. 2.1%, p = 0.16). A two-fold higher PCP-HF risk score was associated with a significant 58% (HR = 1.58; 95% CI, 1.48-1.70; p < 0.0001) and 38% (HR = 1.38; 95% CI, 1.32-1.46; p < 0.0001) greater risk of CVD and all-cause mortality, respectively.

conclusionThe PCP-HF risk score predicts CVD and all-cause mortality, in addition to the 10-year risk of incident HF among white and black men and women. These results underline the expanded utility of the PCP-HF risk score and suggest that its implementation in the clinical and population health settings may improve primary CVD prevention in the United States.

Indexed as

Health Status IndicatorsAdultAgedBlack or African AmericanCause of DeathElectrocardiographyFemaleHealth StatusHeart FailureHumansIncidenceMaleMiddle AgedNutrition SurveysPredictive Value of TestsPrognosisBlood pressureCardiovascular diseasesElectrocardiographyEpidemiologyHeart failureMortalityNHANESPrimary preventionRiskSocial determinants of health

Identifiers

PMID32334524
PMCPMC7183589
OpenAlexW3017453857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.